USP Chapter <800>: Updating your Assessment of Risk

Activity Preview

Since the U.S. Pharmacopeia (USP) General Chapter <800> became official in December 2019, pharmacists have ensured compliance with standards for handling hazardous drugs—from receipt through waste disposal. This includes pharmacists considering both personnel and design strategies for their compounding space as well as implementation of safe, effective, and practical containment strategies and work practices. What’s the purpose of USP <800> and the assessment of risk—and how does it protect pharmacist staff? Get answers to these questions and more at this session.

Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Discuss the purpose of the U.S. Pharmacopeia (USP) General Chapter <800>.
  2. Identify types of hazardous drug exposures and explain the responsibilities of staff handling hazardous drugs.
  3. List the resources that can be used to identify hazardous drugs.
  4. Identify personnel training and facility elements that are needed to comply with USP <800>.

Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2

Accreditation Information


The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-007-H07-P

To obtain credit for USP Chapter <800>: Updating your Assessment of Risk, participants will need to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

Initial release date: March 15, 2021
Expiration date: March 15, 2024 - No credit granted after this date


USP Chapter <800>: Updating your Assessment of Risk is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association


Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 


This learning product is a component of the APhA2021 Virtual Education package.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-21-007-H07-P 0.1 CEUs March 15, 2021 - March 15, 2024